Top Markets
Coin of the day
Becton, Dickinson and Company Becton, Dickinson and Company

Becton, Dickinson and Company

BDX
주식 순위 #389
Becton, Dickinson and Company develops, manufactures, and sells medical... Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.
주가
$154.51
시가총액
$55.98B
변동 (1일)
-1.82%
변동 (1년)
-32.08%
국가
US
거래 Becton, Dickinson and Company (BDX)

카테고리

Becton, Dickinson and Company (BDX)의 발행 주식 수
December 2025 기준 발행 주식 수: 285.07M
Becton, Dickinson and Company의 최신 재무 보고서와 주가에 따르면 현재 발행 주식 수는 285.07M입니다. September 2024 말 기준 회사는 289.76M주를 발행했습니다. 발행 주식 수는 일반적으로 주식 분할이나 자사주 매입에 의해 영향을 받습니다.
Becton, Dickinson and Company (BDX)의 발행 주식 수 기록 (2000 ~ 2026)
매년 말 기준 발행 주식 수
연도 발행 주식 수 변화
2026 (TTM) 285.07M -0.54%
2025 286.61M -1.09%
2024 289.76M 1.22%
2023 286.28M 0.45%
2022 285.01M -1.48%
2021 289.29M 3.70%
2020 278.97M 3.34%
2019 269.94M 4.49%
2018 258.35M 18.00%
2017 218.94M 2.93%
2016 212.70M 5.02%
2015 202.54M 4.78%
2014 193.30M -0.95%
2013 195.16M -5.01%
2012 205.46M -7.11%
2011 221.18M -5.61%
2010 234.33M -2.56%
2009 240.48M -1.57%
2008 244.32M -0.35%
2007 245.19M -0.92%
2006 247.46M -1.62%
2005 251.53M 0.01%
2004 251.51M -1.19%
2003 254.54M -1.37%
2002 258.07M 0.27%
2001 257.37M 1.64%
2000 253.23M 0.00%
유사 기업 또는 경쟁사의 발행 주식 수
회사 발행 주식 수 차이 국가
354.90M 24.49%
US
345.26M 21.11%
DE
338.57M 18.77%
JP
489.30M 71.64%
CH
146.47M -48.62%
US